This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Neuracle Science Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Tae Woo Kim
Introduction
Tae Woo Kim is a notable inventor based in Gunpo-si, South Korea. He has made significant strides in the field of pharmaceuticals, particularly in cancer treatment. His work focuses on the use of specific antibodies to promote blood vessel normalization, which is crucial in combating cancer.
Latest Patents
Tae Woo Kim holds a patent for the use of anti-FAM19A5 antibodies for treating cancers. This patent outlines the pharmaceutical application of antagonists that specifically bind to FAM19A5. The goal of this innovation is to promote blood vessel normalization and treat diseases, such as cancer, in subjects who require such interventions.
Career Highlights
Throughout his career, Tae Woo Kim has demonstrated a commitment to advancing medical science. His innovative approach to cancer treatment has the potential to improve patient outcomes significantly. He is currently associated with Neuracle Science Co., Ltd., where he continues to contribute to groundbreaking research.
Collaborations
Tae Woo Kim collaborates with esteemed colleagues, including Bongcheol Kim and Eun Bee Cho. Their combined expertise enhances the research and development efforts at Neuracle Science Co., Ltd.
Conclusion
Tae Woo Kim's contributions to the field of cancer treatment through his innovative patent highlight his role as a leading inventor. His work not only showcases his dedication to medical advancements but also offers hope for improved therapeutic strategies in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile